{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-007464","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.977849+00:00","generated_at":"2026-05-16T01:47:00.944624+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"bioAffinity Technologies releases case study showing CyPath Lung helps avoid biopsy in elderly patient","bullets":["CyPath Lung test was negative for a 79-year-old woman with suspicious LDCT finding, supporting surveillance over invasive biopsy.","Repeat CT scan in October 2025 showed nodule resolved, validating the conservative management decision.","Test demonstrated 92% sensitivity, 87% specificity, and 88% accuracy for detecting lung cancer in nodules <2 cm.","Case study highlights CyPath Lung's role in reducing unnecessary procedures in high-risk patients."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-007464","json":"https://secwatch.observer/filing/0001493152-26-007464.json","markdown":"https://secwatch.observer/filing/0001493152-26-007464.md","text":"https://secwatch.observer/filing/0001493152-26-007464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226007464/0001493152-26-007464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226007464/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:47:00.944624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}